Delivery Order SPE2DB20D3101-SPE2DB25FQTJ4

Award Date 10/22/24
Potential Completion Date 10/23/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB22D3009|SPE2DB25FAH17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,083.96 firm fixed-price delivery order is for the supply of 4,566,196,865 units of the antibiotic medication Cefazolin 2 g/50 ml-dextrose. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6DBL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a $2,167.92 Firm Fixed Price Delivery Order for the supply of 4,566,383,974 units of Cefazolin 2 G/50 ML-Dextroses, a pharmaceutical product. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. Amerisourcebergen Drug Corp is a major...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.56, is a Firm Fixed Price Delivery Order for the supply of cefazolin 2 g/50 ml-dextrose medical products. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,211.80 firm fixed-price delivery order, awarded on August 26, 2024, is for the supply of 4,565,586,219 units of cefazolin 1 g/50 ml-dextrose solution. The contract has an ultimate completion date of August 27, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.37 firm fixed-price delivery order is for the supply of Cefazolin 2 g/50 ml-Dextroses, a critical medical commodity. The contract has an ultimate completion date of November 18, 2024 and was awarded on November 15, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,083.96, is for the delivery of 4565910632 - Cefazolin 2 G/50 ML-Dextroses, a critical medical product. This is a Firm Fixed Price Delivery Order contract with a completion date of September 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,968,915 units of the pharmaceutical product Cefazolin 2 G/50 ML-Dextroses. The contract, valued at $3,478.11, has an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,959.52 firm-fixed-price delivery order is for the supply of CEFAZOLIN 1 G/50 ML-DEXTROSES, a medical product, with an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Cefazolin 2g/50ml-dextrose medical supplies. The contract has a ceiling value of $1,066.87 and is a firm fixed-price delivery order with an ultimate completion date of April 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of cefazolin 2 g/50 ml-dextrose medical products. The contract has a ceiling value of $1,084.96 and is a firm fixed-price delivery order type with a period of performance through February 12, 2025. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a significant Indefinite...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FQTJ4
    Delivery Order

This federal contract award, with ID SPE2DB20D3101|SPE2DB25FQTJ4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,881.80 firm fixed-price delivery order is for the supply of 4,566,178,222 units of the drug Cefazolin 1 G/50 ML-Dextroses.

The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of that larger IDC.

The contract does not have a set-aside designation, indicating open competition. As a major supplier of pharmaceutical and medical products to federal agencies, particularly the military and veterans' healthcare systems, Amerisourcebergen's federal contract awards demonstrate its critical role in supporting the healthcare needs of government beneficiaries.

Generated 2/27/25, 1:34 PM